Reply to: “Comment on ‘Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case control study’”

Publication date: December 2018

Source: Journal of the American Academy of Dermatology, Volume 79, Issue 6

Author(s): Outi Varpuluoma, Laura Huilaja, Kaisa Tasanen

https://ift.tt/2OB2UbW